Acadia Pharmaceuticals Company Profile

Aggregated data from the web about Acadia Pharmaceuticals

Company Name	Acadia Pharmaceuticals
Website	https://www.acadia-pharm.com
Snippet	Acadia is trailblazing breakthroughs in neuroscience to elevate life through science. We are at the forefront of healthcare, fighting for breakthroughs in our science, our therapies and the way we work, but also in the lives of the people we serve. At Acadia, we are committed to our purpose: we fight disease so more you shines through.
Type	Public
Founded	1993
Revenue	US$339.08 million (2019)
Website	acadia-pharm.com
Formerly	Receptor Technologies
Industry	Biopharmaceutical, Healthcare
Products	Pimavanserin
Traded as	NASDAQ: ACAD, Russell 2000 component
Key people	Stephen R. Davis, CEO
Net income	US$−235.26 million (2019)
Headquarters	San Diego, California, U.S.
Total assets	US$783.18 million (2019)
Total equity	US$699.14 million (2019)
Operating income	US$−246.55 million (2019)
Number of employees	570 (June 30, 2020)

Acadia Pharmaceuticals is part of the United States company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.